Hers vs TrimRx: Which GLP-1 Provider Is Better?
Short answer: Hers scores higher on our rubric, 7.3/10 against 5.3/10. Full reasoning, pricing and the cases where the other one wins are below.
Hers beats TrimRx overall, scoring 7.3/10 vs 5.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; TrimRx is published $179/mo; total not verified. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path. Choose TrimRx for cash-pay shoppers willing to verify the exact drug, first-order charge and follow-up price at checkout before authorizing payment.
A side-by-side look at Hers and TrimRx to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hers
#30 of 54The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.
Visit HersTrimRx
#47 of 54Cash-pay compounded GLP-1 provider offering semaglutide and a dual-agonist option it labels 'GLP-1 + GIP.' Its landing advertises a $179 floor, while its terms list semaglutide at $199 for the first order and $299 for follow-ups, and GLP-1 + GIP at $349 then $399. That conflict, plus a corroborated billing and fulfillment complaint pattern, is central to our 5.3/10 score.
Visit TrimRx| Feature | Hers | TrimRx |
|---|---|---|
| Why each one | A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. | A written lost-or-damaged shipment replacement promise and both compounded molecule classes through one intake; neither resolves the first-party price conflict or fulfillment record. |
| Our Score | 7.3/10 | 5.3/10 |
| Headline Price | $188 first month, then $298/mo | published $179/mo; total not verified |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path | Cash-pay shoppers willing to verify the exact drug, first-order charge and follow-up price at checkout before authorizing payment |
| Watch out for | Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings. | The advertised $179 floor conflicts with TrimRx's own terms: semaglutide is listed at $199 for the first order and $299 for follow-ups; GLP-1 + GIP is $349 first and $399 follow-up. Treat the total as unresolved until checkout |
| Ranking | #30 | #47 |
| Get started | Visit Hers | Visit TrimRx |
Pros & Cons Compared
Hers
Pros
- +FDA-approved brand paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199; with the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
TrimRx
Pros
- +Offers both compounded semaglutide and a compounded GLP-1 + GIP option through one intake
- +The landing advertises a $179 entry floor, although that figure does not match the medication schedule in the official terms
- +Onboarding takes under 15 minutes with same-day provider review for most applications
- +Free medication replacement if your shipment is lost or damaged in transit
Cons
- −The advertised $179 floor conflicts with TrimRx's own terms: semaglutide is listed at $199 for the first order and $299 for follow-ups; GLP-1 + GIP is $349 first and $399 follow-up. Treat the total as unresolved until checkout
- −Trustpilot is 3.6/5 across 5,485 reviews with 32% one-star; BBB rates TrimRx F/not accredited with 728 unanswered and 221 unresolved complaints
- −The same paid-but-no-medication, billing, refund and fulfillment themes recur across BBB and Trustpilot, meeting our rubric's cross-platform -3.0 fulfillment-failure threshold
- −Compounded only, no brand-name Wegovy or Zepbound. Compounded drugs are not FDA-approved finished products.
- −No insurance billing and no superbill for out-of-network reimbursement, so treat the monthly price as a pure cash-pay number
Our Verdict
Hers edges out TrimRx with a score of 7.3/10 vs 5.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; TrimRx is published $179/mo; total not verified. Hers offers both brand-name and compounded medications, giving you more flexibility.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Hers and TrimRx.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Hers vs GobyMedsfrom $99/mo
- Hers vs DudeMedsfrom $149/mo
- Hers vs PeterMDfrom $165/mo
- TrimRx vs Shedfrom $199/mo
- TrimRx vs Galafrom $149/mo
- TrimRx vs Henry Medsfrom $199/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Hers · 7.3/10